A layer one that behaves like an exchange
Injective is finance infrastructure first and a general purpose chain second, with an order book and derivatives primitives built into the protocol. If your product is a market, this is a short path to one.
INJ right now.
Pulled live every time this page loads. We do not hardcode market figures, because a stale number on an agency site is worse than no number at all.
What Injective is actually for.
Injective is a Cosmos SDK chain with fast finality and an unusual decision at its core. A central limit order book lives in the protocol itself rather than inside a smart contract. Exchange logic, derivatives markets and oracle plumbing are chain level modules any application can call, which means a team can launch a market without writing a matching engine. It also supports smart contract environments alongside those modules, so builders are not forced to choose between native performance and familiar tooling.
What people actually do here is trade. Perpetual futures, spot markets, prediction and structured products, real world asset markets and various automated strategies make up most of the activity, and interoperability with the wider Cosmos network plus bridges to other major chains keeps assets flowing in. Because multiple front ends can share the same underlying order book, liquidity is not fragmented across competing applications the way it is on chains where every exchange runs its own pools. That shared liquidity is the strongest argument for building here.
The culture follows the design. Injective's audience is traders, quants and market makers, not collectors. Conversations are about spreads, funding rates, oracle latency and listing mechanics. Consumer projects tend to struggle for oxygen, while anything giving sophisticated users a new market or a better execution path gets attention quickly. It is a narrow chain, and that is deliberate. The people who choose it are usually running from general purpose networks where their product was one of a thousand things competing for the same feed.
What the INJ token actually does.
The mechanics matter to you because the network token is the thing your own token competes with for the same attention and the same balance sheet.
Gas and settlement
INJ pays transaction fees across the chain and functions as a settlement and collateral asset within several of its markets, so demand is tied to activity rather than to holding alone.
Staking and security
Validators bond INJ and delegators stake to them, earning a share of issuance and fees. Security economics are standard proof of stake, with slashing for misbehavior.
Governance
Market listings, parameter changes and protocol upgrades run through onchain governance, so staked holders decide which markets exist. Getting a market listed is a political process as much as a technical one.
Fee driven burn
A recurring auction collects fees contributed by applications on the chain and uses the proceeds to buy and burn INJ, tying supply reduction directly to how much the network is used.
Injective pairs ongoing staking issuance with a burn mechanism fed by application fees, so net supply change depends on how much the chain is actually used. Issuance rewards validators and delegators while the burn auction removes tokens in proportion to fee flow. The design intent is that a busier chain is a tighter one. What matters for a founder is less the arithmetic and more the incentive it creates. Applications that route fees into the auction are visibly contributing to the network, and that contribution is watched.
That shapes the attention economy. On Injective a new project competes with staking yield and with the burn narrative, both of which are well understood by the holder base. Loose emissions land badly with an audience that thinks in funding rates. The projects that get traction usually launch a market rather than a token, prove volume, then discuss token design. If you do issue one, expect questions about fee routing, about whether the token accrues anything, and about how it behaves when volumes fall.
Who you are actually launching to.
The single most useful question about any chain, and the one most founders answer last.
Derivatives traders
Active users who came for perpetuals and stayed for the fee structure. They evaluate a new product by depth and execution quality within minutes of opening it.
Quant and market making desks
Firms running automated strategies who need reliable oracle data, predictable block behavior and an order book they can model. They are the difference between a live market and a dead one.
Cross chain builders
Teams using Cosmos interoperability to source assets from elsewhere and give them markets here, rather than trying to build a self contained economy on one chain.
Good fit for
What to watch
- This is a finance chain. Consumer, gaming and collectible projects get very little natural attention here, and a mint that would find an audience elsewhere can go unnoticed no matter how good the work is.
- Shared liquidity cuts both ways. If a competing front end trades against the same order book, your differentiation has to come from experience, distribution or products, not from owning the liquidity itself.
- Markets need market makers. Launching a pair without committed liquidity providers produces a listing nobody can trade, and Orca does not make markets, so that relationship is yours to build.
Launching on Injective with Orca Web3.
The deliverables are the same everywhere. What changes per chain is everything about how they are made.
Positioning against the order book
Since anyone can access the same markets, we build the argument for why traders should use your front end. Usually that is a specific user, a specific product design and a sharper interface, framed clearly.
Trading interface design
We design the actual surface: order entry, position management, funding and risk display. Trading interfaces are a specialist discipline and generic dashboard design loses users fast.
Governance and listing narrative
New markets pass through onchain governance. We prepare the proposal, the supporting explanation and the community campaign around it, so a listing vote is not your first introduction to the chain.
Token launch on Injective
Positioning, identity, litepaper, tokenomics design, launch site and TGE campaign.
RWA issuance
Institutional grade brand and disclosure aware communications for tokenized assets.
dApp front end
Wallet flows, chain switching and transaction states built for this network's tooling.
Launching on Injective, answered.
Why build here instead of on an EVM rollup?
Because the exchange primitives already exist. On most chains, launching a derivatives venue means building or forking a matching system, sourcing liquidity into your own pools and maintaining oracle infrastructure. Injective provides those as protocol modules with liquidity shared across applications, which removes months of engineering and the cold start problem that kills most new venues. The trade is a narrower audience and a smaller pool of general purpose developers. If you are building a market, that trade usually favors Injective. If you are building a consumer app, it does not.
Can we get a new market listed?
Market creation runs through governance, so the answer depends on convincing staked holders the market is worth having. That means an oracle source people trust, a plausible liquidity plan and a clear explanation of who will trade it. Teams that show up on the day of the vote with no prior presence tend to have a hard time. Build the relationship first, publish the reasoning, answer the technical questions in public, then propose. The vote is the end of the process rather than the start.
Does our token need to feed the burn auction?
It is not mandatory, but participation is visible and the community notices. Contributing application fees to the auction ties your product's success to the chain's supply dynamics and buys goodwill with the people whose attention you need. Whether it makes sense depends on your revenue model, because fees routed to the auction are fees you do not keep. Model it honestly rather than committing for optics, and be clear in your materials about what portion goes where, since holders will work it out anyway.
What does Orca do for an Injective launch?
Brand and naming, the narrative and litepaper, trading interface and front end design, launch site, listing and governance materials, and the campaign around going live. We do not write or audit contracts, provide liquidity, or make claims about returns. On this chain the highest value work is usually the interface and the argument for why a sophisticated trader should move, because access to the underlying market is not itself a differentiator.
Chains a project weighing Injective usually looks at too.
Building on Injective?
Bring us the project and the date. We will tell you what it takes, whether Injective is the right room for it, and what we would do differently if it is not.
Injective and the INJ mark are trademarks of their respective owners and appear here to indicate a network we work on, not to imply endorsement, partnership or affiliation. Nothing on this page is financial, investment, tax or legal advice, and no asset named here is a recommendation to buy or hold anything.